Cargando…

Use of Non-Steroidal Anti-Inflammatory Drugs and Associated Gastroprotection in a Cohort of Workers

Background: This study describes the prevalence of non-steroidal anti-inflammatory drug (NSAID) use, and analyses prescribing patterns of NSAIDs and associated gastroprotection. Methods: The study population consisted of 5650 workers at the General Motors automobile assembly plant in Zaragoza, Spain...

Descripción completa

Detalles Bibliográficos
Autores principales: Lallana, María Jesús, Feja, Cristina, Aguilar-Palacio, Isabel, Malo, Sara, Rabanaque, María José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163830/
https://www.ncbi.nlm.nih.gov/pubmed/30149590
http://dx.doi.org/10.3390/ijerph15091836
_version_ 1783359455571738624
author Lallana, María Jesús
Feja, Cristina
Aguilar-Palacio, Isabel
Malo, Sara
Rabanaque, María José
author_facet Lallana, María Jesús
Feja, Cristina
Aguilar-Palacio, Isabel
Malo, Sara
Rabanaque, María José
author_sort Lallana, María Jesús
collection PubMed
description Background: This study describes the prevalence of non-steroidal anti-inflammatory drug (NSAID) use, and analyses prescribing patterns of NSAIDs and associated gastroprotection. Methods: The study population consisted of 5650 workers at the General Motors automobile assembly plant in Zaragoza, Spain. NSAID prescription data for 2014 were obtained from the prescription database of Aragon (Spain). NSAID consumption was determined based on the number of defined daily doses purchased per year. Heavy NSAIDs users were identified using Lorenz curves. Results: NSAID use in the cohort was high (40.7% of workers, 95% CI 39.4–41.9). The prescription of proton pump inhibitors increased with age. Gastrointestinal protection was lacking in some participants who were being treated with drugs associated with a high risk of gastrointestinal bleeding. Heavy NSAID users (defined as those above the 95th percentile of consumption), accounted for 26% of total DDDs, and consumed a greater proportion of coxibs than non-heavy users. Conclusions: The rate of NSAID consumption in the cohort was high. To reduce the risk of gastrointestinal complications, monitoring and adequate gastroprotection are essential in patients who are prescribed NSAIDs for long periods of time or who are treated concomitantly with drugs that increase the risk of gastrointestinal bleeding.
format Online
Article
Text
id pubmed-6163830
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-61638302018-10-12 Use of Non-Steroidal Anti-Inflammatory Drugs and Associated Gastroprotection in a Cohort of Workers Lallana, María Jesús Feja, Cristina Aguilar-Palacio, Isabel Malo, Sara Rabanaque, María José Int J Environ Res Public Health Article Background: This study describes the prevalence of non-steroidal anti-inflammatory drug (NSAID) use, and analyses prescribing patterns of NSAIDs and associated gastroprotection. Methods: The study population consisted of 5650 workers at the General Motors automobile assembly plant in Zaragoza, Spain. NSAID prescription data for 2014 were obtained from the prescription database of Aragon (Spain). NSAID consumption was determined based on the number of defined daily doses purchased per year. Heavy NSAIDs users were identified using Lorenz curves. Results: NSAID use in the cohort was high (40.7% of workers, 95% CI 39.4–41.9). The prescription of proton pump inhibitors increased with age. Gastrointestinal protection was lacking in some participants who were being treated with drugs associated with a high risk of gastrointestinal bleeding. Heavy NSAID users (defined as those above the 95th percentile of consumption), accounted for 26% of total DDDs, and consumed a greater proportion of coxibs than non-heavy users. Conclusions: The rate of NSAID consumption in the cohort was high. To reduce the risk of gastrointestinal complications, monitoring and adequate gastroprotection are essential in patients who are prescribed NSAIDs for long periods of time or who are treated concomitantly with drugs that increase the risk of gastrointestinal bleeding. MDPI 2018-08-24 2018-09 /pmc/articles/PMC6163830/ /pubmed/30149590 http://dx.doi.org/10.3390/ijerph15091836 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lallana, María Jesús
Feja, Cristina
Aguilar-Palacio, Isabel
Malo, Sara
Rabanaque, María José
Use of Non-Steroidal Anti-Inflammatory Drugs and Associated Gastroprotection in a Cohort of Workers
title Use of Non-Steroidal Anti-Inflammatory Drugs and Associated Gastroprotection in a Cohort of Workers
title_full Use of Non-Steroidal Anti-Inflammatory Drugs and Associated Gastroprotection in a Cohort of Workers
title_fullStr Use of Non-Steroidal Anti-Inflammatory Drugs and Associated Gastroprotection in a Cohort of Workers
title_full_unstemmed Use of Non-Steroidal Anti-Inflammatory Drugs and Associated Gastroprotection in a Cohort of Workers
title_short Use of Non-Steroidal Anti-Inflammatory Drugs and Associated Gastroprotection in a Cohort of Workers
title_sort use of non-steroidal anti-inflammatory drugs and associated gastroprotection in a cohort of workers
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163830/
https://www.ncbi.nlm.nih.gov/pubmed/30149590
http://dx.doi.org/10.3390/ijerph15091836
work_keys_str_mv AT lallanamariajesus useofnonsteroidalantiinflammatorydrugsandassociatedgastroprotectioninacohortofworkers
AT fejacristina useofnonsteroidalantiinflammatorydrugsandassociatedgastroprotectioninacohortofworkers
AT aguilarpalacioisabel useofnonsteroidalantiinflammatorydrugsandassociatedgastroprotectioninacohortofworkers
AT malosara useofnonsteroidalantiinflammatorydrugsandassociatedgastroprotectioninacohortofworkers
AT rabanaquemariajose useofnonsteroidalantiinflammatorydrugsandassociatedgastroprotectioninacohortofworkers